Skip to main content
. 2019 Sep 18;10(10):687. doi: 10.1038/s41419-019-1917-2

Fig. 7. Effects of p38 MAPK pathway inhibitor SB239063 in dynasore induced anti-OS in vivo.

Fig. 7

a The representative mouse and tumors of the xenograft mouse modes in DMSO, SB239063 (10 mg/kg), dynasore (10 mg/kg) and combination-treated groups. b Tumor volumes were measured every day since day 3 after model establishment (day 0), and drugs administration were initiated at day 4 (red arrow). c Tumor samples of four xenograft mice groups were under H&E staining (Scare bar: 40 μm). d, e Xenograft tumor tissues were subjected to IHC staining by using Ki67 antibody (Scare bar: 40 μm). *p < 0.05 and **p < 0.01 vs. DMSO group